Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 161

Related Citations for PubMed (Select 22664224)

1.
2.

Reactogenicity of two 2010 trivalent inactivated influenza vaccine formulations in adults.

Leeb A, Carcione D, Richmond PC, Jacoby P, Effler PV.

Vaccine. 2011 Oct 19;29(45):7920-4. doi: 10.1016/j.vaccine.2011.08.073. Epub 2011 Aug 22.

PMID:
21864621
3.

Fever following administration of two inactivated influenza vaccines--a survey of parents of New Zealand infants and children 5 years of age and under.

Petousis-Harris H, Poole T, Booy R, Turner N.

Vaccine. 2011 Apr 5;29(16):2933-7. doi: 10.1016/j.vaccine.2011.02.012. Epub 2011 Feb 21.

PMID:
21338679
4.

Safety and immunogenicity of 2010-2011 H1N12009-containing trivalent inactivated influenza vaccine in children 12-59 months of age previously given AS03-adjuvanted H1N12009 pandemic vaccine: a PHAC/CIHR Influenza Research Network (PCIRN) study.

Langley JM, Scheifele DW, Quach C, Vanderkooi OG, Ward B, McNeil S, Dobson S, Kellner JD, Kuhn S, Kollman T, MacKinnon-Cameron D, Smith B, Li Y, Halperin SA.

Vaccine. 2012 May 14;30(23):3389-94. doi: 10.1016/j.vaccine.2012.03.046. Epub 2012 Mar 30.

PMID:
22469860
5.

Trivalent influenza vaccine and febrile adverse events in Australia, 2010: clinical features and potential mechanisms.

Blyth CC, Currie AJ, Wiertsema SP, Conway N, Kirkham LA, Fuery A, Mascaro F, Geelhoed GC, Richmond PC.

Vaccine. 2011 Jul 18;29(32):5107-13. doi: 10.1016/j.vaccine.2011.05.054. Epub 2011 Jun 1.

PMID:
21640152
6.

Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.

Englund JA, Walter EB, Gbadebo A, Monto AS, Zhu Y, Neuzil KM.

Pediatrics. 2006 Sep;118(3):e579-85.

7.
8.

Epidemiological study of severe febrile reactions in young children in Western Australia caused by a 2010 trivalent inactivated influenza vaccine.

Armstrong PK, Dowse GK, Effler PV, Carcione D, Blyth CC, Richmond PC, Geelhoed GC, Mascaro F, Scully M, Weeramanthri TS.

BMJ Open. 2011 May 30;1(1):e000016. doi: 10.1136/bmjopen-2010-000016.

9.

Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?

Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA.

Pediatrics. 2006 Sep;118(3):e570-8.

10.

Increased reactions to pediatric influenza vaccination following concomitant pneumococcal vaccination.

Van Buynder PG, Frosst G, Van Buynder JL, Tremblay FW, Ross A, Jardine C, Fei BG.

Influenza Other Respir Viruses. 2013 Mar;7(2):184-90. doi: 10.1111/j.1750-2659.2012.00364.x. Epub 2012 Apr 12.

PMID:
22498052
11.

Risk of convulsions in children after monovalent H1N1 (2009) and trivalent influenza vaccines: a database study.

Stowe J, Andrews N, Bryan P, Seabroke S, Miller E.

Vaccine. 2011 Nov 28;29(51):9467-72. doi: 10.1016/j.vaccine.2011.10.029. Epub 2011 Oct 20.

PMID:
22019757
12.

Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011.

Tse A, Tseng HF, Greene SK, Vellozzi C, Lee GM; VSD Rapid Cycle Analysis Influenza Working Group.

Vaccine. 2012 Mar 2;30(11):2024-31. doi: 10.1016/j.vaccine.2012.01.027.

PMID:
22361304
13.

Seasonal influenza vaccines.

Fiore AE, Bridges CB, Cox NJ.

Curr Top Microbiol Immunol. 2009;333:43-82. doi: 10.1007/978-3-540-92165-3_3. Review.

PMID:
19768400
14.

General practice encounters following seasonal influenza vaccination as a proxy measure of early-onset adverse events.

Dey A, Gidding HF, Menzies R, McIntyre P.

Vaccine. 2014 Apr 17;32(19):2204-8. doi: 10.1016/j.vaccine.2014.02.044. Epub 2014 Mar 6.

PMID:
24613527
15.

Safety and tolerability of a 2009 trivalent inactivated split-virion influenza vaccine in infants, children and adolescents.

Lambert SB, Chuk LM, Nissen MD, Nolan TM, McVernon J, Booy R, Heron L, Richmond PC, Walls T, Marshall HS, Reynolds GJ, Hartel GF, Hu W, Lai MH.

Influenza Other Respir Viruses. 2013 Sep;7(5):676-85. doi: 10.1111/irv.12107. Epub 2013 Apr 2.

PMID:
23551933
16.
17.
18.

Risk of fever after pediatric trivalent inactivated influenza vaccine and 13-valent pneumococcal conjugate vaccine.

Stockwell MS, Broder K, LaRussa P, Lewis P, Fernandez N, Sharma D, Barrett A, Sosa J, Vellozzi C.

JAMA Pediatr. 2014 Mar;168(3):211-9. doi: 10.1001/jamapediatrics.2013.4469.

PMID:
24395025
19.

Safety and immunogenicity of an inactivated thimerosal-free influenza vaccine in infants and children.

Nolan T, Richmond PC, McVernon J, Skeljo MV, Hartel GF, Bennet J, Basser RL.

Influenza Other Respir Viruses. 2009 Nov;3(6):315-25. doi: 10.1111/j.1750-2659.2009.00108.x.

PMID:
19903213
20.

The risk of fever following one dose of trivalent inactivated influenza vaccine in children aged ≥6 months to <36 months: a comparison of published and unpublished studies.

Kaczmarek MC, Duong UT, Ware RS, Lambert SB, Kelly HA.

Vaccine. 2013 Nov 4;31(46):5359-65. doi: 10.1016/j.vaccine.2013.09.005. Epub 2013 Sep 19. Review.

PMID:
24055353
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk